FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 251 filers reported holding FATE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,467,000 | -68.1% | 89,425 | -51.8% | 0.49% | -58.9% |
| Q4 2021 | $10,852,000 | -16.5% | 185,476 | -15.4% | 1.19% | +9.2% |
| Q3 2021 | $12,998,000 | -9.4% | 219,299 | +32.7% | 1.09% | +12.6% |
| Q2 2021 | $14,346,000 | +58.4% | 165,299 | +50.5% | 0.97% | +39.8% |
| Q1 2021 | $9,054,000 | +21.4% | 109,807 | +33.9% | 0.69% | +4.8% |
| Q4 2020 | $7,456,000 | -0.8% | 82,000 | -56.4% | 0.66% | -10.3% |
| Q3 2020 | $7,514,000 | -2.7% | 188,000 | -16.4% | 0.74% | +1.7% |
| Q2 2020 | $7,720,000 | – | 225,000 | – | 0.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
| Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
| Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
| Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
| DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
| Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
| Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
| Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
| ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |